SCHEMBL4201093

SCHEMBL4201093

O=C(CCl)c1cc2[nH]c(=O)[nH]c2cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
MAPK1 P28482 1/20 0.49
HIF1A Q16665 1/20 0.49
LMNA P02545 4/20 0.43
MAPT P10636 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
RAB9A P51151 2/20 0.43
HTT P42858 1/20 0.43
PAX8 Q06710 1/20 0.43
GSK3B P49841 5/20 0.42
GRIA1 P42261 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 3/20 0.41
GRIN2D O15399 3/20 0.41
GRIN3B O60391 3/20 0.41
GRIN1 Q05586 3/20 0.41
GRIN2A Q12879 3/20 0.41
GRIN2B Q13224 3/20 0.41
GRIN2C Q14957 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8543005 0.86 ALDH1A1 (0.41) ALDH1A1MAPK1HIF1ALMNAMAPT
SCHEMBL4195687 0.76 CMA1 (0.45) ALDH1A1MAPK1HIF1ALMNAMAPT
SCHEMBL4204225 0.75 PRKAG1 (0.41) ALDH1A1MAPK1LMNAMAPTSMN1; SMN2
SCHEMBL4197956 0.74 THRB (0.36) LMNAMAPTSMN1; SMN2GRIA1MEN1
SCHEMBL640124 0.73 GRIA1 (0.70) ALDH1A1LMNAMAPTSMN1; SMN2GRIA1
SCHEMBL27787713 0.72 ALDH1A1 (0.42) ALDH1A1MAPK1HIF1ALMNAMAPT
SCHEMBL4194809 0.71 ALDH1A1 (0.58) ALDH1A1MAPK1HIF1ALMNAMAPT
SCHEMBL9516561 0.69 ALDH1A1 (0.55) ALDH1A1MAPK1HIF1ALMNAMAPT
SCHEMBL27735955 0.69 ALDH1A1 (0.50) ALDH1A1MAPK1HIF1ALMNAMAPT
SCHEMBL8543146 0.68 MAPT (0.40) ALDH1A1MAPK1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090130165-A1 MIF Inhibitors CORTICAL PTY LTD 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090130165-A1 MIF Inhibitors MIF, MMP12, IL4 ALDH1A1 780/4885MAPK1 940/4885HIF1A 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.